# Utility of the SomaLogic Cardiovascular Disease (CVD) Secondary Risk Panel for Cardiovascular Risk

> **NCT03599531** · — · COMPLETED · sponsor: **SomaLogic, Inc.** · enrollment: 244 (actual)

## Conditions studied

- Cardiovascular Risk Factor
- Cardiovascular Diseases

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03599531
- **Lead sponsor:** SomaLogic, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-13
- **Primary completion:** 2020-10-10
- **Final completion:** 2020-10-10
- **Target enrollment:** 244 (ACTUAL)
- **Last updated:** 2021-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03599531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03599531, "Utility of the SomaLogic Cardiovascular Disease (CVD) Secondary Risk Panel for Cardiovascular Risk". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03599531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*